Pentixapharm has brought in almost 20 million euros ($22 million) from an IPO, with the German biotech earmarking the ...

Kurma plans to raise a total of 250 million euros ($276 million) for the fund, dubbed Biofund IV, which would make it the ...

One of those companies, a contract research organization focused on genetic medicines called Franklin Biolabs, officially ...

Septerna is about to find out how a biotech without “any meaningful clinical data” fares in the late 2024 IPO market. | ...

Siemens Healthineers has received a new go-ahead from the FDA for what the company describes as its first completely ...

The digital pathology developer Proscia is launching an artificial intelligence toolkit for life science researchers, ...

Legend Biotech appears to be on a mission to shake up its cell therapy development. | A week after signing up to collaborate ...

GigaGen’s prior work with the DOD produced polyclonal antibodies that can neutralize two botulinum neurotoxins, which are ...

Precision medicines biotech Relay Therapeutics is shedding about 10% of its workforce in efforts to streamline the ...

The FDA is getting the word out on a mandatory software update from Philips for its Trilogy line of portable life support ...

Synchron has reported that its miniature brain-computer interface implant, threaded up through the blood vessels to help read ...

Big Pharma is investing heavily in AI to slash development timelines and foster innovation. | Big Pharma is investing heavily ...